Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jun 18;12(6):1813.
doi: 10.3390/nu12061813.

Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study

Affiliations
Randomized Controlled Trial

Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study

Jeffrey M Beckett et al. Nutrients. .

Abstract

Gastroesophageal reflux disease (GERD) affects approximately 20% of Australians. Patients suffer a burning sensation known as heartburn due to the movement of acidic stomach content into the esophagus. There is anecdotal evidence of the effectiveness of prebiotic sugarcane flour in controlling symptoms of GERD. This pilot study aimed to investigate the effectiveness of a prebiotic sugarcane flour in alleviating symptoms in medically-diagnosed GERD patients. This pilot study was a single center, double-blinded, placebo-controlled randomized trial conducted on 43 eligible participants. The intervention group (n = 22) were randomized to receive 3 g of sugarcane flour per day, and the control group (n = 21) received 3 g of cellulose placebo per day. Symptoms of gastroesophageal reflux disease were assessed before and after three weeks treatment using the validated Gastroesophageal Reflux Disease-Health Related Quality of Life questionnaire (GERD-HRQL). After three weeks there were significant differences in symptoms for heartburn, regurgitation, and total symptoms scores (p < 0.05) between the sugarcane flour and placebo. Mean GERD-HRQL scores increased in the placebo group for regurgitation (mean increase 1.7; 95% CI 0.23 to 3.2; p = 0.015) and total symptom scores (2.9; 95% CI 0.26 to 5.7; p = 0.033). In contrast, there were significant reductions in heartburn (mean decrease -2.2; 95% CI -4.2 to -0.14; p = 0.037) and total symptom scores (-3.7; 95% CI -7.2 to -0.11; p = 0.044) in the intervention group. This pilot study has shown significant positive effects of sugarcane flour in the reduction of GERD symptoms, and a larger randomized controlled trial is warranted.

Keywords: dietary fiber; gastroesophageal reflux disease; heartburn; regurgitation; sugarcane flour.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart representing the pilot study.
Figure 2
Figure 2
Individual participant changes in self-reported GERD-HRQL symptom scores after 3 weeks of intervention. Heartburn symptom score (a), regurgitation symptom score (b), and total symptom score (c) changes after 3 weeks of intervention. Bar charts show mean values. a p < 0.05. GERD-HRQL: Gastroesophageal Reflux Disease-Health Related Quality of Life; PSCF: prebiotic whole plant sugar cane flour.

Similar articles

Cited by

References

    1. Sandhu D.S., Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver. 2018;12:7–16. doi: 10.5009/gnl16615. - DOI - PMC - PubMed
    1. Morozov S., Isakov V., Konovalova M. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease. World J. Gastroenterol. 2018;24:2291–2299. doi: 10.3748/wjg.v24.i21.2291. - DOI - PMC - PubMed
    1. Ronkainen J., Aro P., Storskrubb T., Lind T., Bolling-Sternevald E., Junghard O., Talley N.J., Agreus L. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population—The kalixanda study. Aliment. Pharmacol. Ther. 2006;23:1725–1733. doi: 10.1111/j.1365-2036.2006.02952.x. - DOI - PubMed
    1. Miller G., Wong C., Pollack A. Gastro-oesophageal reflux disease (gord) in australian general practice patients. Aust. Fam. Physician. 2015;44:701. - PubMed
    1. Lagergren J., Bergström R., Lindgren A., Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999;340:825–831. doi: 10.1056/NEJM199903183401101. - DOI - PubMed

Publication types